DKK1 and Miyoshi myopathy: Moreover, this study highlights the potential for exploring other bone anabolic agents in clinical practice, such as intermittent PTH or Dkk1-ab, which have been shown to exhibit bone anabolic potential in the context of MM [50, 51, 52, 53].